<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Endothelial CD39 metabolizes <z:chebi fb="13" ids="16761">ADP</z:chebi> released from activated platelets </plain></SENT>
<SENT sid="1" pm="."><plain>Recombinant soluble human CD39 (solCD39) potently inhibited ex vivo platelet aggregation in response to <z:chebi fb="13" ids="16761">ADP</z:chebi> and reduced cerebral <z:mpath ids='MPATH_124'>infarct</z:mpath> volumes in mice following transient middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp>, even when given 3 hours after <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Postischemic platelet and <z:mpath ids='MPATH_179'>fibrin deposition</z:mpath> were decreased and perfusion increased without increasing <z:hpo ids='HP_0001342'>intracerebral hemorrhage</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>In contrast, aspirin did not increase postischemic blood flow or reduce infarction volume, but did increase <z:hpo ids='HP_0001342'>intracerebral hemorrhage</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Mice lacking the enzymatically active extracellular portion of the CD39 molecule were generated by replacement of exons 4-6 (apyrase-conserved regions 2-4) with a PGKneo cassette </plain></SENT>
<SENT sid="5" pm="."><plain>Although CD39 <z:chebi fb="2" ids="33699">mRNA</z:chebi> 3' of the <z:chebi fb="0" ids="7507">neomycin</z:chebi> cassette insertion site was detected, brains from these mice lacked both apyrase activity and CD39 immunoreactivity </plain></SENT>
<SENT sid="6" pm="."><plain>Although their baseline phenotype, hematological profiles, and <z:mp ids='MP_0001914'>bleeding</z:mp> times were <z:mpath ids='MPATH_458'>normal</z:mpath>, cd39(-/-) mice exhibited increased cerebral <z:mpath ids='MPATH_124'>infarct</z:mpath> volumes and reduced postischemic perfusion </plain></SENT>
<SENT sid="7" pm="."><plain>solCD39 reconstituted these mice, restoring postischemic cerebral perfusion and rescuing them from cerebral injury </plain></SENT>
<SENT sid="8" pm="."><plain>These data demonstrate that CD39 exerts a protective thromboregulatory function in <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
</text></document>